Pete Schultz - Information

of one

Dr. Peter G. Schultz Bio

Dr. Peter G. Schultz was born on June 23, 1956, in Cincinnati, Hamilton County, Ohio. He currently resides in San Diego, San Diego County, California. He is currently the Scientific Adviser of 5AM Venture Management LLC and the Academic Adviser of Achaogen. In February 2018, he became the chair of the Scientific Advisory Board and a member of the Scientific Advisory Board of WuXi Biologics (Cayman) Inc. "His contributions to science include the discovery of catalytic antibodies, methodology that expands the genetic codes of living organisms and the development and application of combinatorial methods in chemistry and biology including the first generation of combinatorial materials libraries".

Educational career

Dr. Peter G. Schultz obtained a B. Sc. in Chemistry in 1979 from California Institute of Technology, Berkeley. He then went on to obtain his PhD. from the same school in 1984. His thesis work was on "generation and characterization of 1,1-diazenes and the generation of sequence-selective polypyrrole DNA binding/cleaving molecules". He was at the Massachusetts Institute of Technology for a year before joining the chemistry faculty at the University of California. During his time at the University of California, he was a Professor of Chemistry from 1985-1998, an Investigator of the Howard Hughes Medical Institute in 1994, and the Principal Investigator at Lawrence Berkeley National Laboratory in 1985. In 1999, he joined the Faculty of Scripps, where he was a Professor of Chemistry and the President for The Scripps Family. In 2015, he was appointed to the position of CEO at The Scripps Research Institute (TSRI). Dr. Peter G. Schultz has co-authored 600 scientific journals and has trained over 300 graduate and post-doctoral students.

Research interest

In a 2011 publication, Dr. Peter G. Schultz areas of interest were:

• Catalytic Antibodies
• Application of molecular diversity to problems in biomolecular recognition and catalysis, drug discovery, and materials science.
• Development of methods for incorporating unnatural amino acids and base pairs selectively into proteins and nucleic acids.
• Single-molecule biological imaging.
• Functional genomics.

This publication is outside the standard 2-year time frame for a typical Wonder request. However, this publication was included in order to provide more value.


He has founded a number of institutions focused on chemistry, material science, and medicine, and has served as the Director of each institution at some point in their respective histories. He holds close to 100 patents. The institutions that he established are provided below.

• He was the founder of the Genomics Institute of the Novartis Research Foundation (GNF), San Diego, serving as the Institute Director from 1999-2010.
• He founded the not-for-profit California Institute for Biomedical Research (CALIBR) in 2012.
• In 1988, he established his first biotech company, Affymax Research Institute.
• He is the founder of Takeda California.
• He is the co-founder of Syrrx
• He is a co-founder of Kalypsys
• He established Phenomix
• He founded Symyx Therapeutics
• In 2002, he co-founded Ilypsa
• In 2003, he co-founded Ambrx.
• He co-founded Ardelyx
• He co-founded Wildcat Technologies, "pioneers in the application of diversity based approaches to problems in chemistry, materials science, and medicine".


Dr. Peter G. Schultz has received many awards and acknowledgments for his scientific achievements. He has received the following awards;

• In 1988, he was awarded the Waterman Award of the National Science Foundation.
• In 1990, he was given the ACS Award in Pure Chemistry.
• In 1992, he claimed the UC Berkeley College of Chemistry Teaching Award.
• He was awarded membership in the National Academy of Sciences in 1993 and National Institute of Medicine in 1998.
• In 1994, he claimed the Wolf Prize in Chemistry.
• In 2000, he received the ACS Alfred Bader Award in Bioorganic Chemistry.
• In 2002, he received the Paul Erhlich and Ludwig Darmstaedter Award.
• In 2006, he was awarded The Arthur C. Cope Award American Chemical Society.
• In 2013, he was named top transnational researcher by Nature Biotechnology.
• In 2013, he received The Laureate Chemistry for the Future Solvay Prize and Wieland Prize.
• He was awarded the 2016 Heinrich Wieland Prize.


To wrap up, Dr. Peter G. Schultz, born on June 23, 1956, got a B. Sc. in Chemistry in 1979 from the California Institute of Technology in Berkeley. He then obtained his PhD. from the same school in 1984. He has held advisory and directory positions at various institutions. Schultz has founded and co-founded over 12 research institutions and has also received many awards and acknowledgment for his significant impact on science.